Go to deals
Other Industries

Challenger Exploration has raised US$32.8 million

Challenger Exploration (ASX:CEL) has completed a fundraising. The raise was strongly supported by domestic and international institutions, both new and existing, with a cornerstone investment from a globally renowned investor.

Challenger Exploration, led by an experienced management team, aspires to become a globally significant gold producer. The company is developing two complementary gold/copper deposits in South America. The strategy for the Hualilan Gold Project is for it to provide a high-grade, low capex operation in the near term. This underpins Challenger with a low risk, high margin source of cash flow while, it prepares for a much larger bulk gold operation in Ecuador.

Oaklins’ team in Australia acted as joint lead manager to the raise.

Talk to the deal team

Justin Lewis

Managing Director
Melbourne, Australia
Oaklins Henslow

Related deals

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Construction & Engineering Services

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland

Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.

Learn more
Duke Capital Limited has completed a fundraising
Financial Services

Duke Capital Limited has completed a fundraising

Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more